ALTEN Calsoft Labs, a leading Enterprise Digital Transformation solutions and Engineering R&D services company, has launched – “BioPharma Ledger”, a Blockchain clinical trial platform.
Clinlogix, a leading-edge global clinical research organization (CRO), with locations in Europe, Asia, South America and the US will be the first practitioner to pilot and implement the platform in real-world clinical trials.
JeanMarie Markham, the Founder and CEO of Clinlogix said:
“I’m very excited to be one of the first, if not the first, CRO who is moving ahead with the rapid development and deployment of a blockchain-based platform which will become an industry standard. Clinlogix has always embraced new technologies that improve patient outcomes, safety and health along with helping our sponsors to get new treatments to market rapidly, efficiently and cost-effectively. We are a decidedly different CRO and the new blockchain technology complements our ‘Innovation Pathway’ culture for all of our people and our customers.”
This reinforces ALTEN Calsoft Labs’ continued commitment to bringing Digital led transformation to industry-specific areas. The Blockchain practice provides customers with enterprise blockchain solutions in innovative business initiatives covering everything from business strategy and ideation to development and full enterprise scale. “The Blockchain for clinical trials is our first initiative in the broader Blockchain practice at ALTEN Calsoft Labs. We will make a significant impact on the clinical trial process with our scalable Blockchain platform that will ultimately address many key core processes in the Life Sciences industry. This will pave the way to fundamental changes in other key verticals that will demonstrate savings in costs, time and efficiency – all with the meaningful added benefits of security and trust,” says Paul Elisii, Vice President of BI and Blockchain, ALTEN Calsoft Labs.
“Blockchain will introduce us all to a new age of transparency, privacy and traceability in all aspects of the Life Sciences as we know them. It is as transformational to pharma, biotech and medical devices today, as the Internet was to communications 20 years ago. Blockchain has the power to fundamentally shift many core processes for drug research and development by increasing patient safety and privacy, improving quality of data, and significantly shortening the length of clinical trials,” says Nick Spring, Life Sciences Partner, ALTEN Calsoft Labs. “We are looking forward to working with the team at Clinlogix on this innovative approach.”
The newly created Blockchain Platform for clinical trials will leverage the BlockApps STRATO middleware platform. BlockApps is a founding member of the Enterprise Ethereum Alliance (EEA), the world’s largest open source blockchain initiative, and has the distinction as the first Blockchain platform available on Microsoft Azure, AWS, and Google Cloud.
ALTEN Calsoft Labs (ACL) is a digital transformation, next generation technology consulting and engineering services company. The Company offers Digital, Consulting, Enterprise IT and Product Engineering Services, in verticals like Retail, Healthcare, Life Sciences, Telecom, Manufacturing, Energy & Utilities, Networking, Semiconductor and High-Tech. ACL enables enterprises to Innovate, Integrate, and Transform their business by leveraging disruptive technologies like Blockchain, Digital Interactive, Cloud, Mobility, AI & RPA, Analytics, DevOps, IoT and Software-defined Networking (SDN/NFV).
- Utrust Joins Forces with Alternative Airlines for Flight Bookings with Crypto - November 13, 2019
- Dark Web Drug Dealer Pleads Guilty To Using Cryptocurrency to Launder More Than $19 Million - November 13, 2019
- Dutch Police Bust CEO of Blockchain Game Firm, Komodore64 – €78 million Gone? - November 13, 2019
- Celsius Hits over $4 Billion in Crypto Loans – Leading the Industry - November 12, 2019
- Coinbase Introduces Staking Rewards on Tezos - November 6, 2019
- Volvo Cars to implement blockchain traceability of cobalt used in electric car batteries - November 6, 2019
- EU-Funded Acceleration Project, LEDGER, Offering Support Services and Up to €200k Equity-Free for Blockchain Data Governance Projects - November 6, 2019
- Global Financial System Regulators – the Financial Action Task Force – Issue Draft Guidance on Digital Identity - November 5, 2019
- David Chaum Releases XX Alpha Messenger Promising Unprecedented User Privacy - November 5, 2019
- Æternity Blockchain Developers Plan to Take On Ethereum With Final Hardfork – Handing over Governance to the Community - November 5, 2019
- Researchers Claim Cross-border B2B Blockchain Transactions set to Explode to $4.4 Trillion by 2024 - November 5, 2019
- Global Companies Unite to Unveil Comprehensive Framework for Tokenization – It’s About Time - November 5, 2019
- Microsoft Kicks Off Enterprise-ready Crypto Token Platform On Azure – Predicts Tokenization Is A Pillar Of The Coming Revolution In Multi-Party Applications That Blockchain Technology Ushered In - November 5, 2019
- Polish-British Blockchain Company Billon to Digitise Euro in Deal with Raiffeisen Bank International - November 5, 2019
- 500.com Limited Releases Intel on Blockchain Technology for China’s Lottery Industry - November 4, 2019
- Oxfam, Etherisc, and Aon Find Success with First Blockchain-Based Agricultural Insurance Policies for Smallholder Farmers in Sri Lanka - November 4, 2019
- Interview: Brock Pierce and Two Prime’s Alexander S. Blum - November 4, 2019
- Samsung Bullish on Blockchain – Pushing for Developers on New Samsung Blockchain Platform SDK - November 1, 2019
- Busted: SEC and CFTC Nail First Global Credit – a Swiss Security-Based Bitcoin Swaps Dealer That Allegedly Aimed at American Investors - November 1, 2019
- Zilliqa and Oxford Women in Computer Science Society Join to Bring Diversity to Blockchain Sector - November 1, 2019
Also published on Medium.